Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Sterility Testing Market by Product (Kits & Reagents, Instrument, Services), Test (Membrane Filtration, Direct Inoculation), Application (Pharma, Biological Manufacturing, Medical Device Manufacturing), End User (Pharma, Biotech) & Region - Global Forecasts to 2028" report has been added to ResearchAndMarkets.com's offering.
The global sterility testing market is expected to reach USD 1.9 billion in 2028 from USD 1.1 billion in 2023 at a CARG of 10.5%.
Factors such as expanding pharmaceutical & biotechnology production capacities, increasing development of novel biopharmaceutical products, and rising investments in life sciences research are expected to drive market growth. However, the growing adoption of single-use technology and stringent regulatory guidelines for product approval are expected to restrain market growth to a certain extent.
During the forecast period, the kits & reagent is expected to account for the fastest-growing segment
Based on product & service, the sterility testing market is divided into kits & reagents, instruments, and services. During the forecast period (2023-2028), the kits & reagents segment is also expected to be the fastest-growing segment in the sterility testing market. Kits are widely used in the pharmaceutical and biotechnology industries as it is easy to use.
Moreover, the long shelf life of these products is contributing to their rising adoption in academic institutions and contract research organizations. Sterility testing is mandatory during the clinical and commercial manufacturing of pharmaceutical & biopharmaceutical products. Pharmaceutical & biotechnology companies adopt kits & reagents for sterility testing as it is cost-effective and time-efficient.
In 2022, by application segment, pharmaceutical & biologics accounted for the biggest market share
Based on application, the sterility testing market is divided into pharmaceutical & biologics manufacturing, medical device manufacturing, and other applications.
In 2022, the pharmaceutical and biologics manufacturing segment accounted for the largest share of the application segment in the sterility testing market. Factors responsible for the growth in this segment include the growing, growing pharmaceutical and biopharmaceutical production capacity across the globe.
In 2022, North America accounted for the largest regional share in this market
The market for sterility testing was dominated by North America in 2022. The presence of manufacturing facilities of major pharmaceutical and biopharmaceutical firms in the region will contribute for the huge demand for sterility testing in North America. The market for sterility testing is anticipated to grow in the region as drug approval rates rise.
Also, the demand for pharmaceuticals and biopharmaceuticals in North America are rising due to the rising prevalence of diseases and the expanding patient population. Moreover, the pharmaceutical and biotechnology sectors in North America make substantial R&D investments and are anticipated to experience rapid growth in the coming years.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 192 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $1.1 Billion |
| Forecasted Market Value (USD) by 2028 | $1.9 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Rising Expansion of Pharmaceutical & Biopharmaceutical Production Capacities
- Increasing Development of Novel Biopharmaceutical Products
- Rising Investments in Life Sciences Research
Restraints
- Growing Adoption of Single-Use Technology
- Stringent Regulatory Guidelines for Product Approval
Opportunities
- Emerging Markets
- Increasing Outsourcing of Services to Sterility Testing Providers
Challenges
- Shortage of Skilled Professionals
Companies Mentioned
- Astell Scientific Ltd.
- BD
- Biomerieux SA
- Boston Analytical
- Charles River Laboratories
- Genscript
- Himedia Laboratories
- Lexamed
- Merck KGaA
- Nelson Laboratories, LLC
- Neopharm Labs Inc.
- Pace Analytical
- Pacific Biolabs
- Pall Corporation (Part of Danaher Corporation)
- Rapid Micro Biosystems, Inc.
- Samsung Biologics
- Sartorius AG
- Sgs SA
- Singota Solutions
- Solvias AG
- Tentamus
- Thermo Fisher Scientific Inc.
- Wuxi Apptec
For more information about this report visit https://www.researchandmarkets.com/r/8w3nk4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
